Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.35 USD | +1.44% | +0.68% | -62.29% |
04-30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
04-30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
Sales 2024 * | 646M 51.48B | Sales 2025 * | 663M 52.77B | Capitalization | 271M 21.6B |
---|---|---|---|---|---|
Net income 2024 * | 9M 717M | Net income 2025 * | 20M 1.59B | EV / Sales 2024 * | 0.14 x |
Net cash position 2024 * | 178M 14.19B | Net cash position 2025 * | 218M 17.35B | EV / Sales 2025 * | 0.08 x |
P/E ratio 2024 * |
29.1
x | P/E ratio 2025 * |
13.4
x | Employees | 634 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.31% |
Latest transcript on Medifast, Inc.
1 day | +1.44% | ||
1 week | +0.68% | ||
Current month | -7.92% | ||
1 month | -19.55% | ||
3 months | -52.06% | ||
6 months | -59.22% | ||
Current year | -62.29% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 02/10/16 |
James Maloney
DFI | Director of Finance/CFO | 56 | 19/07/20 |
Anthony Tyree
COO | Chief Operating Officer | 58 | 31/08/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 02/10/16 |
Jeffrey Brown
BRD | Director/Board Member | 63 | 16/06/15 |
Andrea B. Thomas
BRD | Director/Board Member | 59 | 11/06/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 25 M€ | -2.33% | - |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 25.35 | +1.44% | 453,373 |
10/05/24 | 24.99 | -2.84% | 275,198 |
09/05/24 | 25.72 | +3.04% | 338,668 |
08/05/24 | 24.96 | -2.16% | 336,907 |
07/05/24 | 25.51 | +1.31% | 512,078 |
Delayed Quote Nyse, May 13, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-62.29% | 271M | |
+17.10% | 8.44B | |
+14.30% | 6.77B | |
-3.69% | 3.81B | |
-7.34% | 3.71B | |
+1.78% | 1.4B | |
-28.77% | 1.09B | |
+18.84% | 1.03B | |
-11.81% | 901M | |
-18.34% | 785M |
- Stock Market
- Equities
- MED Stock